These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29735188)

  • 41. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.
    Tommasino F; Durante M; D'Avino V; Liuzzi R; Conson M; Farace P; Palma G; Schwarz M; Cella L; Pacelli R
    Acta Oncol; 2017 May; 56(5):730-736. PubMed ID: 28281862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protons vs Photons for Brain and Skull Base Tumors.
    Ahmed SK; Brown PD; Foote RL
    Semin Radiat Oncol; 2018 Apr; 28(2):97-107. PubMed ID: 29735196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of gastric-cancer radiotherapy performed with volumetric modulated arc therapy or single-field uniform-dose proton therapy.
    Mondlane G; Gubanski M; Lind PA; Ureba A; Siegbahn A
    Acta Oncol; 2017 Jun; 56(6):832-838. PubMed ID: 28281357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.
    Jouglar E; Wagner A; Delpon G; Campion L; Meingan P; Bernier V; Demoor-Goldschmidt C; Mahé MA; Lacornerie T; Supiot S
    PLoS One; 2016; 11(10):e0164643. PubMed ID: 27764132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
    Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
    Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spatially fractionated (GRID) radiation therapy using proton pencil beam scanning (PBS): Feasibility study and clinical implementation.
    Gao M; Mohiuddin MM; Hartsell WF; Pankuch M
    Med Phys; 2018 Apr; 45(4):1645-1653. PubMed ID: 29431867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
    Knäusl B; Fuchs H; Dieckmann K; Georg D
    Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physics controversies in proton therapy.
    Engelsman M; Schwarz M; Dong L
    Semin Radiat Oncol; 2013 Apr; 23(2):88-96. PubMed ID: 23473685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Finding Value for Protons: The Case of Prostate Cancer?
    Ojerholm E; Bekelman JE
    Semin Radiat Oncol; 2018 Apr; 28(2):131-137. PubMed ID: 29735189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
    Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
    Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives.
    Lazarev S; Rosenzweig K; Samstein R; Salgado LR; Hasan S; Press RH; Sharma S; Powell CA; Hirsch FR; Simone CB
    Lung Cancer; 2021 Feb; 152():157-164. PubMed ID: 33421922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of fixed- versus variable-modulation treatment modes for charged-particle irradiation of the gastrointestinal tract.
    Daftari I; Petti PL; Collier JM; Castro JR; Pitluck S
    Med Phys; 1993; 20(5):1387-98. PubMed ID: 8289721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy.
    Lin H; Dong L; Jimenez RB
    Semin Radiat Oncol; 2022 Jul; 32(3):270-281. PubMed ID: 35688525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Scanning Beam for Superficial Dose in Proton Therapy.
    Moskvin VP; Estabrook NC; Cheng CW; Das IJ; Johnstone PA
    Technol Cancer Res Treat; 2015 Oct; 14(5):643-52. PubMed ID: 24945369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
    Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
    Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.